ESC Premium Access

Chronic kidney disease and risk of atrial fibrillation and heart failure in general population-based cohorts - the BiomarCaRE project.

Congress Session

About the speaker

Professor Dietrich Rothenbacher

Ulm (Germany)
0 follower

4 more presentations in this session

Risk of dementia according to smoking cessation after newly diagnosed atrial fibrillation: a nationwide cohort study

Speaker: Doctor H. Lee (Seoul, KR)

Thumbnail

Beta-blocker treatment in atrial fibrillation with chronic obstructive pulmonary disease: a Danish nationwide study from 1995 to 2015

Speaker: Mr C. Benson (Copenhagen, DK)

Thumbnail

Lower risk of stroke after alcohol abstinence in patients with incident atrial fibrillation: a nationwide population-based cohort study

Speaker: Doctor S. Lee (Seoul, KR)

Thumbnail

Comparative effectiveness and safety of edoxaban vs warfarin in patients with atrial fibrillation: a nationwide cohort study

Speaker: Mr P. Nielsen (Aalborg, DK)

Thumbnail

Access the full session

Atrial fibrillation: risks and management

Speakers: Professor D. Rothenbacher, Doctor H. Lee, Mr C. Benson, Doctor S. Lee, Mr P. Nielsen
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

COVID-19 and the risk of thrombosis.

27 August 2021

ESC Premium Access

The COVID-19 pandemic: a multiple (cardiovascular) hit?

27 August 2021

ESC Premium Access

Acute safety and performance outcomes from the inspIRE trial using a novel pulsed field ablation system for the treatment of paroxysmal atrial fibrillation

27 August 2021

This platform is supported by

logo Novo Nordisk